ALFA Finder| Revenue growth | 35.8% YoY to ₹2,739.8 lakhs |
|---|---|
| Margins | EBITDA margin 20.7%, up 210bps; PAT margin down 14bps |
| Demand visibility | Structural tailwinds cited; no quantified demand visibility |
| Management confidence | Confident on long-term Ayurvedic, nutraceutical opportunities |
Growth
Revenue +35.8% YoY to ₹2,739.8L; EBITDA +51.1%; PAT +34.6% vs H1 FY26; PAT margin down 14bps to 16.2%.
Outlook
No numeric guidance given. IPO proceeds to digital marketing, D2C, e-commerce; ₹750L branding spend; export readiness planned.
Risks
Operating cash flow negative at ₹-65.5L; inventory up to ₹1,322.4L; cash conversion cycle 230 days vs 201.
Investor Presentation filed with BSE, BSE: 544943. Summary written with AI assistance from the document.
Himalaya Nutravedics India Ltd: key numbers
- Share price
- ₹169.85
- Market cap
- ₹149.6 Cr
- Revenue (annual)
- ₹43.07 Cr
- Net profit (annual)
- ₹7.39 Cr
- P/E (TTM)
- 20.2×Sector 43.7×
- Promoter holding
- 68.13%
- FII holding
- 6.99%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Himalaya Nutravedics India Ltd
All →Himalaya Nutravedics India Other Announcement
Himalaya Nutravedics' board approved appointment of M/s Srinivasachary & Co. as internal auditor for FY 2026-27. It ratified H1 2026-27 standalone results available on the company website.
Himalaya Nutravedics India H1 FY27 Results: Net Profit ₹4.4 Cr, Up 33.3% YoY
Himalaya Nutravedics approved un-audited H1 FY27 results: revenue of Rs 2741.43 Lakh and profit after tax of Rs 444.11 Lakh. The board also appointed Srinivasachary & Co. as internal auditor.
- Key figure
- Net profit ₹4.4 Cr · +33.3% YoY
Himalaya Nutravedics India Board Meeting Date
HIMALAYA NUTRAVEDICS INDIA has given prior intimation of a board meeting on 12 November 2026 to consider unaudited standalone half-yearly results for the period ended September 2026. The trading window is closed from 1 October 2026 to 14 November 2026.
Himalaya Nutravedics India Other Announcement
Himalaya Nutravedics India Ltd intimated BSE of its updated CIN and MCA master data after listing on the BSE SME Platform. The filing is a routine administrative record update with no financial or operational impact.
Himalaya Nutravedics India Price Movement Clarification
Himalaya Nutravedics India Limited clarified that recent share price movements are market-driven and not linked to any undisclosed price-sensitive information or material events.
Himalaya Nutravedics India Other Announcement
Himalaya Nutravedics India Limited has filed the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.